January 9, 2018
Winter weather blasted much of the nation last week, but it’s not just the common cold that Americans are fighting. Many regions, regardless of temperature, are also being pummeled by a different phenomenon – vaccine-preventable diseases.
January 4, 2018
All mothers want to give their babies a stronger immune system, reduce their risk of SIDS and lower their rate of respiratory infections. But a recent study found black babies may be less able to realize these and other benefits of an exclusive human milk diet.
December 14, 2017
As 2017 draws to a close, let’s take a look back at the highlights in patient access this year.
December 12, 2017
What are new drugs to prevent migraine worth? The question is driving a forthcoming report from cost-effectiveness giant the Institute for Clinical and Economic Review (ICER) – and already eliciting an outpouring of feedback from the migraine patient community.
December 8, 2017
The Institute for Patient Access raised several concerns during ICER’s open input period. Based on the methodology described in the draft scoping document, however, it does not appear that ICER’s cost-effectiveness evaluation will adequately address these issues.
December 7, 2017
Hospital NICUs are getting an early Christmas present: the ability to opt out on tubing that could put their newborn patients at risk.
December 5, 2017
Preventable drug safety issues caused nearly 200,000 deaths across the European Union in 2017. Now the European Medicines Agency is working to address that statistic by improving its drug track-and-trace system, known as EudraVigilance.
November 30, 2017
Who feels the impact of headache disorders and migraine? More people than you may think, according to a new video from The Headache & Migraine Policy Forum.
November 29, 2017
IfPA has concerns that ICER is undertaking the cost effectiveness evaluation of Erenumab before sufficient data exists. However, should the…
November 21, 2017
What’s worse than battling a debilitating, painful and costly disease? Having to convince people that it’s real.